Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study

Overview of attention for article published in BMC Cancer, January 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 43 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 22,392 followers.

Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study. https://t.co/JxnRuihSrO #liversurgery

16 Jan 2018

Reply Repost Favourite

A prospective single centre phase II study on adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine published in BMC Cancer: https://t.co/Z0PWtU5ITk

15 Jan 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.